Jesús Miguel
García-Foncillas López

Investigador fins a 2011

Foto de Jesús Miguel

Foto de Hospital Universitario Central de Asturias

Hospital Universitario Central de Asturias

Oviedo, España

Publicacions en col·laboració amb investigadors/es de Hospital Universitario Central de Asturias (5)

2019

Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer (Scientific Reports, (2019), 9, 1, (2589), 10.1038/s41598-019-39291-2)
Scientific Reports
Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer
Scientific Reports, Vol. 9, Núm. 1

2017

Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib
Scientific Reports, Vol. 7

2011

A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143)
Investigational New Drugs, Vol. 29, Núm. 5, pp. 1038-1044

2009

microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells
Clinical Cancer Research, Vol. 15, Núm. 7, pp. 2281-2290